MCP-1: The role of a novel biomarker in assessing neuroinflammation in Parkinson’s disease and Parkinson-plus syndromes
D. AkramovaTashkent Medical Academy, Neurology, Tashkent, UzbekistanG. RakhimbaevaTashkent Medical Academy, Neurology, Tashkent, UzbekistanTurdikul BobomuratovTashkent Medical Academy, Neurology, Tashkent, UzbekistanDilnoza BobamuratovaTashkent Medical Academy, Tma, Maxillofacial Surgery, Tashkent, UzbekistanBekzod IbodovTashkent Medical Academy, Neurology, Tashkent, Uzbekistan
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba